European Diabetes Conference 2020 - Folkhälsan

16 September 2020

European Diabetes Conference 2020

Many researchers from Folkhälsan Research Center will participate in this years European Diabetes Conference and hold presentations on their areas of expertise.

Since its foundation in 1965, the European Association for the Study of Diabetes (EASD) has been organising an Annual Meeting, which has since become the largest international annual conference on diabetes research in the world.

This year’s conference is held during the incoming week and is fully virtual. Apart from presenting the latest results in diabetes and related research, it will host virtual 3D exhibition and spaces to connect with the global medical scientific community in real-time through chat, call, video and discussion forums.

Niina Sandholm from Folkhälsan Research Center has been invited to speak on “Uric acid: a biomarker or risk factor for disease” and many more of our researchers will hold oral or poster presentations about their areas of expertise.  

External link to the full programme here.

External link to EASD here.

FHRC researchers and their presentations:

22.9

Aila Ahola. Modifiable self-management practices impact morning hypo- and hyperglycemia in type 1 diabetes.

Rim Bouslama. Pascin2 phosphorylation at serine 313 is elevated in diabetic kidney disease.

Stefan Mutter. Waist-height ratio and waist circumference are the best estimators of vsiceral fat in type 1 diabetes independently of diabetic nephropathy. 

23.9.

Marika Eriksson. Cerebral small-vesse disease is associated with the severity of diabetic retinopathy in type 1 diabetes.

Anni Antikainen. Urine metabolites associate with coronary artery disease in type 1 diabetes.

Erika Parente. Waist-height ratio is a predictor of severe retinopathy in adults with type 1 diabetes.

Sari Mäkimattila. Excess risk of thyroid cancer in individuals with type 1 diabetes compared to those without diabetes in Finland: nationwide study.

Krishna Adeshara. Association of advanced glycation end-products with cardiovascular risk parameters in type 1 diabetes individuals with diabetic nephropathy.

Anmol Kumar. Effect of L-type calcium channel blockers on VEGF secretion in retinal cells.

24. 9

Raija Lithovius. Genetic risk for coronary artery disease is comparable to the risk imposed by traditional risk factors in indviduals with type 1 diabetes.

Erkka Valo. Urinary metabolites measured by NMR are associated with genetic variants in indviduals with type 1 diabetes.

Jussi Inkeri. Carotid intima-media thickness and arterial stiffness in silent cerebral microbleeds: a study in neurologically asymptomatic individuals with type 1 diabetes.

Anniina Tynjälä. HbA1c variability is associated with arterial stiffness in type 1 diabetes.

Anni Ylinen. The impact on parental risk factors on the risk of stroke in type 1 diabetes.

25.9                  

Niina Sandholm. No it is only a marker - Uric acid: a biomarker or risk factor for disease - the answer is here.

 

Simon Granroth, Science Communicator